59 related articles for article (PubMed ID: 32885598)
1. Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.
Huang S; Liu Y; Yan W; Zhang T; Wang P; Zhu M; Zhang X; Zhou P; Fan Z; Yu H
Pediatr Rheumatol Online J; 2024 May; 22(1):58. PubMed ID: 38783316
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of macrophage activation syndrome in adult dermatomyositis: A single-center retrospective case-control study.
Zhu D; Ying S; Yang C; Li S; Tang S; Sun C; Fang H; Qiao J
Immun Inflamm Dis; 2024 Jan; 12(1):e1141. PubMed ID: 38270325
[TBL] [Abstract][Full Text] [Related]
3. Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis.
Fan Z; Kernan KF; Qin Y; Canna S; Berg RA; Wessel D; Pollack MM; Meert K; Hall M; Newth C; Lin JC; Doctor A; Shanley T; Cornell T; Harrison RE; Zuppa AF; Sward K; Dean JM; Park HJ; Carcillo JA
Crit Care; 2023 Sep; 27(1):347. PubMed ID: 37674218
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.
García-Pavón S; Yamazaki-Nakashimada MA; Báez M; Borjas-Aguilar KL; Murata C
J Pediatr Hematol Oncol; 2017 Aug; 39(6):445-451. PubMed ID: 28562511
[TBL] [Abstract][Full Text] [Related]
5. Glomerular lipidosis as a feature of renal-limited macrophage activation syndrome in a transplanted kidney: a case report.
Sugisaki K; Uchida T; Iwama S; Okihara M; Akashi I; Kihara Y; Konno O; Kuroda M; Koike J; Iwamoto H; Oda T
BMC Nephrol; 2023 Nov; 24(1):329. PubMed ID: 37936128
[TBL] [Abstract][Full Text] [Related]
6. [Hyperferritinemia in a Chilean Academic Healthcare Network: A Retrospective Study].
Huenur F J; Parodi C M; Aravena G C; Eymin L G; Triantafilo C N; Walkowiak N S; Valenzuela S A; Corsi S Ó
Rev Med Chil; 2023 Apr; 151(4):412-419. PubMed ID: 38687515
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of macrophage activation syndrome and treatment progression.
Dong Y; Wang T; Wu H
Front Immunol; 2024; 15():1389710. PubMed ID: 38736876
[TBL] [Abstract][Full Text] [Related]
8. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
[TBL] [Abstract][Full Text] [Related]
9. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
He L; Yao S; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Front Immunol; 2022; 13():955523. PubMed ID: 36189240
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset Still's disease in Western Australia: Epidemiology, comorbidity and long-term outcome.
Nossent J; Raymond W; Keen H; Preen DB; Inderjeeth CA
Int J Rheum Dis; 2022 Nov; 25(11):1306-1314. PubMed ID: 36004429
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience.
Üsküdar Cansu D; Üsküdar Teke H; Cansu GB; Korkmaz C
Rheumatol Int; 2021 Sep; 41(9):1617-1624. PubMed ID: 34213581
[TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature.
Chang Y; Shan X; Ge Y
Pediatr Rheumatol Online J; 2023 Sep; 21(1):106. PubMed ID: 37735702
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
